Aeterna Wealth
Index Fund · Direct plan · Growth

Motilal Oswal Nifty MidSmall Healthcare Index Fund (Direct)

Motilal Oswal Mutual Fund · benchmark Nifty Midsmall Healthcare TRI · 1.9 years old · AMFI code 153023

B
Track-record rating: 2 of 2 in Index: NIFTY MIDSMALL HEALTHCARE

B (middle of the peer group), score 42.6 out of 100. Describes the past, not a forecast.

Returns against the index

PeriodFundIndex (TRI)DifferenceRank in category
6 months14.7%15.2%-0.5%2 / 2
1 year18.5%19.4%-0.9%2 / 2
3 years (a year)––––
5 years (a year)––––

Growth option, point to point to 5 Nov 2026; periods over a year are annualised (CAGR). Index returns use the total-return index, which includes dividends.

Risk

Tracking difference, 1Y-0.88%
Tracking error, 1Y0.05%

Portfolio

Laurus Labs Limited11.8%
Lupin Limited7.6%
Aurobindo Pharma Limited7.1%
Fortis Healthcare Limited6.2%
Glenmark Pharmaceuticals Limited5.4%
Alkem Laboratories Limited4.8%
Mankind Pharma Limited4.3%
IPCA Laboratories Limited4.1%
Biocon Limited4.0%
Gland Pharma Limited3.5%

Top 10 holdings, September 2026 portfolio.

Common questions

What is the NAV of Motilal Oswal Nifty MidSmall Healthcare Index Fund (Direct plan)?

₹12.78 on 5 Nov 2026 (Growth option).

What is the expense ratio of Motilal Oswal Nifty MidSmall Healthcare Index Fund (Direct)?

0.78% a year; the Regular plan's is 1.20%.

What does Motilal Oswal Nifty MidSmall Healthcare Index Fund invest in?

Its largest holdings are Laurus Labs Limited, Lupin Limited, Aurobindo Pharma Limited, with 30 stocks in all (September 2026 portfolio).

How is Motilal Oswal Nifty MidSmall Healthcare Index Fund rated?

B: 2 of 2 Direct plans in Index: NIFTY MIDSMALL HEALTHCARE, on its track record. This describes the past and is not a recommendation.

Data as of 5 Nov 2026: NAVs from AMFI, index data from NSE Indices, portfolios from Motilal Oswal Mutual Fund's monthly disclosure. Updated every weekday. Read the scheme documents before investing.